Effects of human interferons on human choriocarcinoma cells in vitro and in vivo

Gynecologic Oncology
|September 1, 1986
PubMed

Insights

Human interferons (IFNs) showed limited antiviral and antiproliferative effects on choriocarcinoma cell lines in vitro. However, IFN-beta demonstrated efficacy in suppressing tumor growth in vivo, suggesting potential therapeutic applications.

Area of Science:

  • Immunology
  • Cell Biology
  • Virology

Background:

  • Human interferons (IFNs) are crucial for antiviral defense.
  • Choriocarcinoma cell lines are utilized to study cancer biology and potential therapies.

Purpose of the Study:

  • To investigate the antiviral and antiproliferative activities of human interferons (IFNs) against choriocarcinoma cell lines.
  • To evaluate the in vitro and in vivo efficacy of IFNs in choriocarcinoma models.

Main Methods:

  • Utilized three human choriocarcinoma cell lines (BeWo, HCCM-5, NUC-1).
  • Assessed antiviral activity against vesicular stomatitis virus.
  • Measured [3H]thymidine incorporation and cell growth inhibition.
  • Administered IFN-beta intraperitoneally in xenograft models (hamster cheek pouches, nude mice).

Main Results:

  • Choriocarcinoma cell lines exhibited low sensitivity to the antiviral effects of IFN-alpha, IFN-beta, and IFN-gamma.
  • IFN-alpha effectively induced 2-5A synthetase in all cell lines.
  • IFN-alpha and IFN-beta showed dose-dependent suppression of [3H]thymidine incorporation and slight growth inhibition in BeWo and HCCM-5 cells.
  • IFN-beta suppressed xenograft growth in vivo when administered early.
  • IFN-gamma lacked antiproliferative effects on these cell lines.

Conclusions:

  • Choriocarcinoma cells display weak sensitivity to the antiproliferative activity of human IFNs in vitro.
  • Despite in vitro limitations, IFN-beta shows potential for in vivo tumor growth suppression in choriocarcinoma models.